AUS
NZ
UK
CA
USA
IND
Healthcare
Xenon Pharma (NASDAQ:XENE) Nasdaq Today Charts Biotech Flow
November 13, 2025 12:00 AM PST| By Anmol KhazanchiXenon Pharmaceuticals (NASDAQ:XENE) progresses neuroscience programs while nasdaq today reflects growing attention on advanced biotechnology fields.
10x Genomics (NASDAQ:TXG) Nasdaq Futures Drives Data Biology
November 13, 2025 12:00 AM PST| By Anmol Khazanchi10x Genomics (NASDAQ:TXG) expands advanced single-cell and spatial biology platforms while nasdaq futures reflect shifting trends across global scientific technology sectors.
Novo Nordisk (NYSE:NVO) Builds Momentum In Metabolic Care
November 13, 2025 12:00 AM PST| By Anmol KhazanchiNovo Nordisk (NYSE:NVO) strengthens its role in global healthcare as therapeutic updates shape medical dialogue and reflect continued clinical innovation.
Mettler-Toledo (NYSE:MTD) S&P 500 Today Leads Lab Trends
November 12, 2025 12:00 AM PST| By Anmol KhazanchiMettler-Toledo (NYSE:MTD) continues to enhance laboratory precision and industrial measurement systems, reflecting innovation and accuracy within the s&p 500 today network.
Monte Rosa (NASDAQ:GLUE) Nasdaq Today Shapes Biotech Path
November 12, 2025 12:00 AM PST| By Anmol KhazanchiMonte Rosa Therapeutics (NASDAQ:GLUE) pioneers molecular-glue therapies targeting disease-causing proteins, reflecting biotechnology progress seen across nasdaq today’s innovation landscape.
Mettler-Toledo (NYSE:MTD) S&P 500 Index Elevates Labs
November 11, 2025 12:00 AM PST| By Anmol KhazanchiMettler-Toledo International Inc (NYSE: MTD) advances measurement innovation and laboratory precision within the S&P 500 Index, reflecting technological strength and data-driven industrial performance worldwide.
Eli Lilly (NYSE:LLY) S&P 500 chart Builds Therapeutic Range
November 11, 2025 12:00 AM PST| By Anmol KhazanchiEli Lilly and Company (NYSE:LLY) enhances global healthcare through pharmaceutical innovation and biotechnology leadership, reflecting research-driven excellence among corporations in the s&p 500 chart.
Moderna (NASDAQ:MRNA) Nasdaq Composite ETF Shapes MedTech Rise
November 11, 2025 12:00 AM PST| By Anmol KhazanchiModerna Inc (NASDAQ:MRNA) continues to lead biotechnology through mRNA innovation, global research partnerships, and next-generation therapeutics, reflecting the scientific evolution across the nasdaq composite etf.
Vir Biotechnology (NASDAQ: VIR) Updates and S&P 500 Trends in Healthcare Sector
November 10, 2025 04:55 AM PST| By Anmol KhazanchiVir Biotechnology (NASDAQ: VIR) operates within the healthcare sector, engaging in research and collaborations while appearing in S&P 500, Nasdaq Composite, and Russell 1000 indexes.
Prospera Financial Services Acquires Regeneron Shares Amid Nasdaq Composite
November 10, 2025 04:18 AM PST| By Anmol KhazanchiProspera Financial Services acquires Regeneron Pharmaceuticals (REGN) shares, highlighting activity in the healthcare and biotechnology sector and its relation to major market indices including Nasdaq Composite.
Gyre Therapeutics (Nasdaq: GYRE) Healthcare Stocks Performance Amid S&P 500
November 10, 2025 04:05 AM PST| By Anmol KhazanchiGyre Therapeutics (Nasdaq: GYRE) develops advanced healthcare stocks therapeutics with scientific collaborations and pipeline innovation, aligned with major indices like the S&P 500.
Inspire Medical (NYSE:INSP) Leads Healthcare on NYSE Composite
November 10, 2025 12:00 AM PST| By Anmol KhazanchiInspire Medical Systems (NYSE:INSP) enhances global healthcare through advanced sleep therapy technology, reflecting innovation and sustainability trends shaping the NYSE Composite and the broader medical technology sector.
OmniAb (NASDAQ: OABI) Earnings and Platform Developments in Nasdaq Composite
November 08, 2025 07:28 AM PST| By Anmol KhazanchiOmniAb (OABI) reports earnings updates and details its antibody-discovery platform, highlighting partner programme expansion, financial performance, and strategic focus within the Nasdaq Composite biotechnology sector.
O’Brien Greene & Co’s Position in Amgen Inc. Reflects Healthcare Sector Weight
November 08, 2025 06:35 AM PST| By Anmol KhazanchiO’Brien Greene & Co Inc disclosed a holding in Amgen Inc (NASDAQ: AMGN), a major healthcare stock within the nyse composite index and S&P 500, reflecting its diversified exposure to large-cap healthcare equities.
Abivax Advances in Biopharma Innovation Amid Dow Jones Industrial Average Trends
November 08, 2025 05:41 AM PST| By Anmol KhazanchiAbivax (NASDAQ: ABVX) strengthens its presence in global biopharma with clinical progress, innovative RNA-based therapies, and strategic alignment with indices like the Dow Jones Industrial Average.
Vericel (NASDAQ:VCEL) Nasdaq Composite ETF Elevates Biotech
November 07, 2025 12:00 AM PST| By Anmol KhazanchiVericel Corporation (NASDAQ:VCEL) expands regenerative medicine with advanced cellular therapies in sports medicine and burn care, reflecting innovation and clinical progress within the Nasdaq Composite ETF.
Plus Therapeutics (NASDAQ:PSTV) Highlights ReSPECT-LM Trial Results at SITC Annual Meeting
November 06, 2025 06:08 AM PST| By Team Kalkine MediaHighlights,ReSPECT-LM Phase 1 trial shows favorable safety profile and clinical benefit across multiple measures.,REYOBIQ demonstrated tumor cell reduction with no dose-limiting toxicities up to recommended Phase 2 dose.,Data to be presented at SITC...
Zimmer Biomet (NYSE:ZBH) S&P 500 ETF Sparks MedTech Growth
November 06, 2025 12:00 AM PST| By Anmol KhazanchiHighlights,Zimmer Biomet Holdings Inc. (NYSE:ZBH) maintains leadership in orthopedic innovation.,Broader market momentum reflects trends linked to the s&p 500 etf.,Advancements in medical technology continue to drive precision manufacturing.,Zimmer B...
Pfizer (NYSE:PFE) S&P 500 Mirrors Biotech Market Recovery
November 06, 2025 12:00 AM PST| By Anmol KhazanchiPfizer Inc. (NYSE:PFE) strengthens its global biopharmaceutical leadership through research, vaccine innovation, and therapeutic diversification, mirroring healthcare advancements within the S&P 500.
Zoetis (NYSE:ZTS) S&P 500 Chart Mirrors Pharma Momentum
November 06, 2025 12:00 AM PST| By Anmol KhazanchiZoetis Inc. (NYSE:ZTS) leads animal health advancement through vaccine innovation and global expansion, mirroring the resilience and scientific progress represented within the S&P 500 Chart.
